The idea of using debt to support businesses in healthcare and life sciences tends to be viewed warily and with good reason. At MidAmerica Healthcare Venture Forum this week, GE Capital senior vice president in life sciences Joe Hammer offered up some helpful insights on the different kinds of debt available to biotech and medical […]
Hospitals and other healthcare firms are feeling more confident about their economic stability, according to a recent survey from GE Capital. The survey, which focused on c-suite executive as mid market companies ranging from $10 million to $1 billion in assets, found that “healthcare firms continue to enjoy improving financial performance and increasing employment.” Much […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
According to a press release, GE Capital’s Healthcare Financial Services has named Brett B. Haring leader of its Life Sciences Finance business. Haring has worked for GE Capital for 25 years, mostly in GE Capital’s equipment finance business. Recently, he was senior managing director of GE Capital’s Corporate Finance business for the U.S. eastern and […]
Implementation of the Affordable Care Act – and the uncertainty it’s bringing with it – will be the biggest headache for the healthcare industry this year, according to a new poll of industry executives. But despite unanswered questions about how millions of newly insured Americans will affect healthcare costs, hospital volumes and the insurance industry, […]
With the generic cliff receding, R&D pipelines continuing to improve and FDA approvals of biopharmaceuticals up, opportunities outweigh the risks for investors in the biopharmaceuticals industry. The key for the industry going forward will be to continue to improve R&D productivity and commercialize drugs that represent a true advance to current treatment.
Healthcare IT can improve the quality of care by capturing data or identifying drug interactions, but the HIT industry has its challenges. Healthcare reform is affecting how people invest in the HIT industry, but the outlook for this industry remains bright.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The following post is sponsored by GE Capital Healthcare Financial Services. Against a backdrop of slowing healthcare expenditures and ongoing implementation of the Affordable Care Act (ACA), the dynamics of the U.S. medical device industry have become increasingly fluid. In this article, Elliot Hyun, a medical device analyst at GE Capital Healthcare Financial Services, discusses […]
Massachusetts-based medical device company Infraredx has refinanced its debt with GE Capital. GE Capital upped the coronary artery imaging company’s credit from $6.6 million to $20 million, according to a press release. The company is gearing up for a commercial launch in Japan and will use much of the funding earmarked for commercialization as working […]
Nearly 90 percent of healthcare service leaders polled said they were anticipating mergers and acquisitions within the next year, according to the results of a GE Capital, Healthcare Financial Services survey of 223 senior level executives in healthcare services. This is to allow businesses to grow during a tough economy, Darren Alcus, CEO of GE […]